These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25858663)

  • 1. Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons.
    Chew KW; Bhattacharya D; McGinnis KA; Horwich TB; Tseng CH; Currier JS; Butt AA;
    AIDS Res Hum Retroviruses; 2015 Jul; 31(7):718-22. PubMed ID: 25858663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.
    Lo Re V; Volk J; Newcomb CW; Yang YX; Freeman CP; Hennessy S; Kostman JR; Tebas P; Leonard MB; Localio AR
    Hepatology; 2012 Nov; 56(5):1688-98. PubMed ID: 22619086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients.
    Fernández-Montero JV; Barreiro P; de Mendoza C; Labarga P; Soriano V
    J Viral Hepat; 2016 Jan; 23(1):47-52. PubMed ID: 26390144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population.
    Kakinami L; Block RC; Adams MJ; Cohn SE; Maliakkal B; Fisher SG
    Int J Clin Pract; 2013 Jan; 67(1):6-13. PubMed ID: 23241046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients.
    Lim JK; Tate JP; Fultz SL; Goulet JL; Conigliaro J; Bryant KJ; Gordon AJ; Gibert C; Rimland D; Goetz MB; Klein MB; Fiellin DA; Justice AC; Lo Re V
    Clin Infect Dis; 2014 May; 58(10):1449-58. PubMed ID: 24569533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Differential Effects of Human Immunodeficiency Virus and Hepatitis C Virus on Bone Microarchitecture and Fracture Risk.
    Bedimo RJ; Adams-Huet B; Poindexter J; Brown G; Farukhi I; Castanon R; Turner D; Moore T; Tebas P; Maalouf NM
    Clin Infect Dis; 2018 Apr; 66(9):1442-1447. PubMed ID: 29145609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfection.
    Byrne DD; Newcomb CW; Carbonari DM; Nezamzadeh MS; Leidl KB; Herlim M; Yang YX; Hennessy S; Kostman JR; Leonard MB; Localio AR; Lo Re V
    J Viral Hepat; 2015 Nov; 22(11):936-47. PubMed ID: 25754215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".
    Kohli P; Ganz P; Ma Y; Scherzer R; Hur S; Weigel B; Grunfeld C; Deeks S; Wasserman S; Scott R; Hsue PY
    J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes.
    Behzadpour D; Ahmadi Vasmehjani A; Mousavi Nasab SD; Ahmadi NA; Baharlou R
    Pathog Glob Health; 2016; 110(7-8):310-315. PubMed ID: 27830997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection.
    Scherzer R; Heymsfield SB; Rimland D; Powderly WG; Tien PC; Bacchetti P; Shlipak MG; Grunfeld C;
    AIDS; 2017 Jan; 31(1):71-79. PubMed ID: 27677166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfected.
    Meijide H; Pértega S; Rodríguez-Osorio I; Castro-Iglesias Á; Baliñas J; Rodríguez-Martínez G; Mena Á; Poveda E
    AIDS; 2017 May; 31(8):1099-1107. PubMed ID: 28441174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
    Price JC; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski SM; Tien PC
    Hepatology; 2017 Mar; 65(3):853-863. PubMed ID: 27981599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection.
    Ogdie A; Pang WG; Forde KA; Samir BD; Mulugeta L; Chang KM; Kaplan DE; Amorosa VK; Kostman JR; Reddy RK; Schumacher RH; Lo Re V
    BMC Musculoskelet Disord; 2015 Apr; 16():93. PubMed ID: 25896674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals.
    Griesbeck M; Valantin MA; Lacombe K; Samri-Hassimi A; Bottero J; Blanc C; Sbihi Z; Zoorob R; Katlama C; Guiguet M; Altfeld M; Autran B;
    AIDS; 2017 Jun; 31(9):1223-1234. PubMed ID: 28492391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women.
    Lo Re V; Lynn K; Stumm ER; Long J; Nezamzadeh MS; Baker JF; Hoofnagle AN; Kapalko AJ; Mounzer K; Zemel BS; Tebas P; Kostman JR; Leonard MB
    J Infect Dis; 2015 Sep; 212(6):924-33. PubMed ID: 25754980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy.
    Milazzo L; Lai A; Calvi E; Ronzi P; Micheli V; Binda F; Ridolfo AL; Gervasoni C; Galli M; Antinori S; Sollima S
    HIV Med; 2017 Apr; 18(4):284-291. PubMed ID: 27477612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of treatment eligibility for hepatitis C virus in HCV-monoinfected versus HCV/HIV-coinfected persons in electronically retrieved cohort of HCV-infected veterans.
    Butt AA; McGinnis K; Skanderson M; Justice AC
    AIDS Res Hum Retroviruses; 2011 Sep; 27(9):973-9. PubMed ID: 21338329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
    Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Moll A; Jäger H; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
    HIV Med; 2018 Apr; 19(4):299-307. PubMed ID: 29368456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.
    Sangal RB; Taylor LE; Gillani F; Poppas A; Klinger JR; Ventetuolo CE
    Ann Am Thorac Soc; 2014 Dec; 11(10):1553-9. PubMed ID: 25375659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection.
    Gowda C; Brown TT; Compher C; Forde KA; Kostman J; Shaw PA; Tien PC; Lo Re V
    AIDS; 2016 Oct; 30(16):2519-2528. PubMed ID: 27490638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.